IP Verse

Pohlman patent opposition analysis

The comprehensive analysis of Pohlman opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Pohlman

Stay updated with the latest patent oppositions filed by Pohlman

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4339284
Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKU CORPORATIONMay 27, 2026POHLMAN
EP3377534
Treatment Of Lung Cancer Using A Combination Of An Anti-Pd-1 Antibody And An Anti-Ctla-4 AntibodyBRISTOL-MYERS SQUIBB COMPANYMar 18, 2026POHLMAN
EP2818163
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBHFeb 26, 2025RATIOPHARM
EP4069368
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 15, 2025DORRIES
EP3630946
Cell Culture MethodsUCB BIOPHARMADec 23, 2024POHLMAN
EP3530670
Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKU CORPORATIONNov 22, 2024POHLMAN
EP3110848
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Nov 13, 2024DORRIES
EP3515465
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS, INC.Nov 7, 2024DORRIES
EP4219687
Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive TherapyJUNO THERAPEUTICS, INC.Oct 29, 2024POHLMAN
EP3167888
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALS, INC.Oct 28, 2024AMGEN TECHNOLOGY IRELAND UNLIMITED

Top clients of Pohlman

Top companies who are the clients of Pohlman

CompanyTotal
POHLMAN29
DR H ULRICH DORRIES22
DORRIES5
PFIZER5
FOUNDATION MEDICINE4
ZOETIS SERVICES3
AMGEN3
DF MP DRRIES FRANK MOLNIA & POHLMAN2
AMGEN TECHNOLOGY IRELAND UNLIMITED2
BREUER1